Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.

Thyroid : official journal of the American Thyroid Association - 1 Mar 2016

Angell Trevor E, Lechner Melissa G, Smith Alison M, Martin Sue E, Groshen Susan G, Maceri Dennis R, Singer Peter A, Epstein Alan L

Abstract excerpt

BACKGROUND: Establishing the preoperative diagnosis and long-term prognosis of differentiated thyroid cancer (DTC) remain challenging in some patients. Myeloid-derived suppressor cells (MDSC) are tumor-induced cells mediating immune tolerance that are detectable in the peripheral blood of cancer patients. The authors previously developed a novel clinical assay to detect the phenotypes of two human MDSC subsets in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloid-Derived Suppressor Cells

Share to Neoplasm Recurrence, Local

Share to Pilot Projects

Share to Thyroid Nodule

Share to Thyroidectomy

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 26756227
DOI: 10.1089/thy.2015.0289
PMCID: PMC4790214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.PMID 26756227Read ↗

Comprehensive Immune Profiling of Medullary Thyroid Cancer.Semantic proximity Read ↗

Cancer Stem Cells in Thyroid Tumors: From the Origin to MetastasisSemantic proximity Read ↗

The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression ProfileSemantic proximity Read ↗

Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment.Semantic proximity Read ↗

Detection of Serum Deoxyribonucleic Acid Methylation Markers: A Novel Diagnostic Tool for Thyroid CancerSemantic proximity Read ↗

Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.Semantic proximity Read ↗

BRAF <sup>V600E</sup> expression in thyrocytes causes recruitment of immunosuppressive STABILIN-1 macrophagesSemantic proximity Read ↗

Papillary Thyroid Carcinoma with Terminal Immune Exhaustion Phenotype Correlates with Increased Risk of Lymph Node Metastasis: A Combined Flow Cytometry and TCGA Validation StudySemantic proximity Read ↗

Correlation of Mismatch Repair Deficiency with Clinicopathological Features and Programmed Death-Ligand 1 Expression in Thyroid CarcinomaSemantic proximity Read ↗

Gene Expression Profiling of Differentiated Thyroid NeoplasmsSemantic proximity Read ↗

IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?Semantic proximity Read ↗

DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.